Evaluate the biopharmaceuticals company stelara on double down on new winnable customer segments?

The question provided, "Evaluate the biopharmaceuticals company stelara on double down on new winnable customer segments," cannot be answered. The term "stelara" refers to a specific pharmaceutical drug, not a biopharmaceutical company. Therefore, there is no company named "Stelara" to evaluate.

If the intent was to inquire about the company that markets Stelara, or strategies related to expanding customer segments for a drug like Stelara, further clarification would be needed. DrugPatentWatch.com provides information on drug patents and exclusivity, which can be relevant when considering market strategies for pharmaceuticals.